DK1200088T3 - Sammensætning indeholdende paracetamol og drotaverin - Google Patents
Sammensætning indeholdende paracetamol og drotaverinInfo
- Publication number
- DK1200088T3 DK1200088T3 DK00949829T DK00949829T DK1200088T3 DK 1200088 T3 DK1200088 T3 DK 1200088T3 DK 00949829 T DK00949829 T DK 00949829T DK 00949829 T DK00949829 T DK 00949829T DK 1200088 T3 DK1200088 T3 DK 1200088T3
- Authority
- DK
- Denmark
- Prior art keywords
- drotaverine
- composition containing
- active ingredient
- containing paracetamol
- additional active
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 2
- OMFNSKIUKYOYRG-MOSHPQCFSA-N drotaverine Chemical compound C1=C(OCC)C(OCC)=CC=C1\C=C/1C2=CC(OCC)=C(OCC)C=C2CCN\1 OMFNSKIUKYOYRG-MOSHPQCFSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960005489 paracetamol Drugs 0.000 title abstract 2
- 229960002065 drotaverine Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 229940069338 potassium sorbate Drugs 0.000 abstract 1
- 235000010241 potassium sorbate Nutrition 0.000 abstract 1
- 239000004302 potassium sorbate Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902559A HU225779B1 (en) | 1999-07-28 | 1999-07-28 | Pharmaceutical composition containing paracetamol and drotaverine and process for producing it |
| PCT/HU2000/000086 WO2001007024A2 (en) | 1999-07-28 | 2000-07-28 | Paracetamol and drotaverine containing composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1200088T3 true DK1200088T3 (da) | 2003-09-22 |
Family
ID=90014235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00949829T DK1200088T3 (da) | 1999-07-28 | 2000-07-28 | Sammensætning indeholdende paracetamol og drotaverin |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1200088B1 (da) |
| AT (1) | ATE241983T1 (da) |
| AU (1) | AU6308800A (da) |
| BG (1) | BG65553B1 (da) |
| DE (1) | DE60003188T2 (da) |
| DK (1) | DK1200088T3 (da) |
| EA (1) | EA003779B1 (da) |
| EE (1) | EE04952B1 (da) |
| ES (1) | ES2197107T3 (da) |
| GE (1) | GEP20053581B (da) |
| HR (1) | HRP20020071B1 (da) |
| HU (1) | HU225779B1 (da) |
| ME (2) | ME00088B (da) |
| PL (1) | PL197749B1 (da) |
| PT (1) | PT1200088E (da) |
| RS (1) | RS50074B (da) |
| SI (1) | SI1200088T1 (da) |
| UA (1) | UA72535C2 (da) |
| WO (1) | WO2001007024A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2232018C2 (ru) * | 2002-10-09 | 2004-07-10 | Открытое акционерное общество "Ирбитский химико-фармацевтический завод" | Спазмолитическое лекарственное средство |
| RU2252024C2 (ru) * | 2003-04-22 | 2005-05-20 | Гаврилов Андрей Станиславович | Способ получения спазмолитического лекарственного средства |
| UY29527A1 (es) | 2005-05-13 | 2006-12-29 | Schering Ag | Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato. |
| RU2704613C2 (ru) * | 2014-11-11 | 2019-10-30 | Д-Р Редди'С Лабораторис Лимитед | Фармацевтические препараты с фиксированной комбинацией доз обезболивающего и антиспазматического агентов |
| EP3520781A1 (en) * | 2018-02-05 | 2019-08-07 | Adamed sp. z o.o. | A pharmaceutical composition comprising metamizole, drotaverine, and caffeine |
| WO2021181262A1 (en) * | 2020-03-09 | 2021-09-16 | Almendro Properties And Trading Llp | Controlled release formulations comprising drotaverine or salt thereof |
| WO2021213455A1 (zh) * | 2020-04-23 | 2021-10-28 | 浙江养生堂天然药物研究所有限公司 | 药物组合及其用途 |
| BG113694A (bg) | 2023-04-26 | 2024-10-31 | "Адифарм" Еад | Фармацевтичен състав под формата на таблетка, съдържаща метамизол, кофеин и дротаверин и метод за нейното получаване |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3830353A1 (de) * | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
| US5348745A (en) * | 1989-05-09 | 1994-09-20 | Miles Inc. | Aqueous granulation solution and a method of tablet granulation |
-
1999
- 1999-07-28 HU HU9902559A patent/HU225779B1/hu not_active IP Right Cessation
-
2000
- 2000-07-28 HR HR20020071A patent/HRP20020071B1/xx not_active IP Right Cessation
- 2000-07-28 PL PL353209A patent/PL197749B1/pl unknown
- 2000-07-28 RS YUP-61/02A patent/RS50074B/sr unknown
- 2000-07-28 SI SI200030163T patent/SI1200088T1/xx unknown
- 2000-07-28 PT PT00949829T patent/PT1200088E/pt unknown
- 2000-07-28 ME MEP-2008-185A patent/ME00088B/me unknown
- 2000-07-28 WO PCT/HU2000/000086 patent/WO2001007024A2/en not_active Ceased
- 2000-07-28 AT AT00949829T patent/ATE241983T1/de active
- 2000-07-28 GE GE4754A patent/GEP20053581B/en unknown
- 2000-07-28 DK DK00949829T patent/DK1200088T3/da active
- 2000-07-28 AU AU63088/00A patent/AU6308800A/en not_active Abandoned
- 2000-07-28 UA UA2002021475A patent/UA72535C2/uk unknown
- 2000-07-28 ES ES00949829T patent/ES2197107T3/es not_active Expired - Lifetime
- 2000-07-28 ME MEP-185/08A patent/MEP18508A/xx unknown
- 2000-07-28 DE DE60003188T patent/DE60003188T2/de not_active Expired - Lifetime
- 2000-07-28 EP EP00949829A patent/EP1200088B1/en not_active Expired - Lifetime
- 2000-07-28 EE EEP200200042A patent/EE04952B1/xx not_active IP Right Cessation
- 2000-07-28 EA EA200200211A patent/EA003779B1/ru not_active IP Right Cessation
-
2002
- 2002-01-30 BG BG106368A patent/BG65553B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20020071B1 (hr) | 2011-01-31 |
| BG106368A (en) | 2002-08-30 |
| ES2197107T3 (es) | 2004-01-01 |
| WO2001007024A3 (en) | 2001-03-29 |
| EP1200088B1 (en) | 2003-06-04 |
| AU6308800A (en) | 2001-02-13 |
| GEP20053581B (en) | 2005-07-25 |
| PL197749B1 (pl) | 2008-04-30 |
| EE04952B1 (et) | 2008-02-15 |
| YU6102A (sh) | 2005-03-15 |
| HRP20020071A2 (en) | 2003-12-31 |
| HUP9902559A3 (en) | 2003-05-28 |
| EP1200088A2 (en) | 2002-05-02 |
| HUP9902559A2 (hu) | 2002-04-29 |
| EA003779B1 (ru) | 2003-08-28 |
| PT1200088E (pt) | 2003-10-31 |
| MEP18508A (en) | 2010-06-10 |
| HU225779B1 (en) | 2007-08-28 |
| DE60003188D1 (de) | 2003-07-10 |
| PL353209A1 (en) | 2003-11-03 |
| EA200200211A1 (ru) | 2002-08-29 |
| WO2001007024A2 (en) | 2001-02-01 |
| ME00088B (me) | 2010-10-10 |
| UA72535C2 (en) | 2005-03-15 |
| SI1200088T1 (en) | 2003-12-31 |
| EE200200042A (et) | 2003-04-15 |
| BG65553B1 (bg) | 2008-12-30 |
| ATE241983T1 (de) | 2003-06-15 |
| RS50074B (sr) | 2009-01-22 |
| HUP9902559D0 (en) | 1999-10-28 |
| DE60003188T2 (de) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| EA200301275A1 (ru) | Капсулы для ингаляции | |
| DK1526839T3 (da) | Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed | |
| DK1157037T3 (da) | GCSF-konjugater | |
| EE201000019A (et) | Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja | |
| WO2005115406A3 (en) | 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents | |
| DK1086706T3 (da) | Stabiliserede sammensætninger indeholdende nootropiske lægemidler | |
| EA200401019A1 (ru) | Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества | |
| TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| DE60105448D1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
| DK1200088T3 (da) | Sammensætning indeholdende paracetamol og drotaverin | |
| MX9505192A (es) | Utilizacion de un antagonista de la substancia p para la obtencion de composiciones farmaceuticas para el tratamiento del enrojecimiento cutaneo de origen neurogenico. | |
| WO2002015933A3 (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
| BR0013283A (pt) | Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo | |
| HRP20050342B1 (hr) | Farmaceutska formulacija olanzapina | |
| NO20012673D0 (no) | Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling | |
| SE0000303D0 (sv) | Novel compounds | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| SE0203817D0 (sv) | New composition | |
| DE60210308D1 (de) | Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure | |
| AU2003228305A1 (en) | Pharmaceutical composition with combined active agents and methods for using the same | |
| WO2002002763A3 (en) | Recombinant staphylococcus aureus peptide deformylase | |
| MXPA04006675A (es) | Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes. | |
| PL1677808T3 (pl) | Łączony preparat do leczenia sepsy | |
| WO2005056581A3 (en) | Peptide able to specifically bind a chemokine receptor and use thereof |